Left atrial appendage (LAA) closure is a procedure used to reduce the risk of stroke in patients with atrial fibrillation. An article in the New England Journal of Medicine addresses the question of whether current recommendations for the procedure should be expanded. Currently, the LAA is closed mainly in patients with atrial fibrillation who cannot take anticoagulant therapy. The article suggests that it could also be considered in patients who are taking anticoagulant therapy but have a high risk of bleeding. Expanding the recommendations could potentially reduce the risk of stroke in a wider group of patients with atrial fibrillation. The article highlights the need for further research to confirm the safety and efficacy of LAA closure in this extended population. The article's conclusions are preliminary and require further clinical studies.